Skin News and Research

RSS

RMC first in N.J. to offer TESSYS minimally invasive surgery for patients with herniated discs

Riverview Medical Center, part of Meridian Neuroscience, today announced it is the only hospital in the state of New Jersey to offer patients the TESSYS surgery method, a minimally invasive procedure for the treatment of herniated discs.

1 Feb 2012

Breast cancer survivors use at-home method to prep their breasts for reconstruction

NewYork-Presbyterian Hospital/Columbia University Medical Center is the first hospital in the New York metro area to offer breast cancer survivors an at-home method for tissue expansion in preparation for breast reconstruction surgery. Patients use a remote control to gradually create a space within their chest wall for a breast implant.

31 Jan 2012

Oral HPV infection more common in men than women: Study

According to a new US study, oral human papillomavirus (HPV) infection is more common among men than women, leading to an increased risk for men of head and neck cancers. HPV causes the majority of cervical cancers, as well as genital and anal - and head and neck cancers.

31 Jan 2012

Roche’s skin cancer drug Erivedge gets FDA nod

The Food and Drugs Administration (FDA) this Monday approved a pill that treats the most common type of skin cancer, basal cell carcinoma.

31 Jan 2012

Study compares needle fasciotomy and conventional surgery for Dupuytren's contractures

For disabling hand contractures caused by Dupuytren's disease, patients prefer a percutaneous needle fasciotomy procedure despite the higher contracture recurrence rate when compared to conventional surgery.

31 Jan 2012

New research gains increased respect for contraceptive method

Imagine a contraceptive that could, with one or two painless 15-minute non-surgical treatments, provide months of protection from pregnancy. And imagine that the equipment needed were already in physical therapists' offices around the world.

31 Jan 2012

FDA approves Genentech's Erivedge for treatment of BCC

Genentech, a member of the Roche Group, today announced that Erivedge (vismodegib) capsule was approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with a type of skin cancer, called basal cell carcinoma (BCC), that has spread to other parts of the body or that has come back after surgery or that their healthcare provider decides cannot be treated with surgery or radiation.

31 Jan 2012

Genentech receives FDA approval for Erivedge to treat basal cell carcinoma

Today, Erivedge (vismodegib) was approved by the U.S. Food and Drug Administration to treat adult patients with basal cell carcinoma, the most common type of skin cancer. The drug is intended for use in patients with locally advanced basal cell cancer who are not candidates for surgery or radiation and for patients whose cancer has spread to other parts of the body.

31 Jan 2012

Modern ultrasound for male contraception

The ideal male contraceptive would be inexpensive, reliable, and reversible. It would need to be long acting but have few side effects. New research published in BioMed Central's open access journal Reproductive Biology and Endocrinology used commercially available therapeutic ultrasound equipment to reduce sperm counts of male rats to levels which would result in infertility in humans.

30 Jan 2012

Leprosy pathogen exploits micro-RNAs to weaken immune response

A team of UCLA scientists has found that the pathogen that causes leprosy has a remarkable ability to avoid the human immune system by inhibiting the antimicrobial responses important to our defenses.

30 Jan 2012

Washington State Medical Association weighs in on legislation in Olympia

More than 140 physicians met with legislators to voice their opinions on several bills that could significantly impact patient access to care and patient safety. The Washington State Medical Association (WSMA), which held its annual Legislative Day this week, is working hard on legislation to preserve programs that are on the cutting block, and promote legislation that would benefit patients.

30 Jan 2012

Non-smoking, non-drinking transplant patients more likely to develop head and neck cancer

Transplant patients who develop head and neck cancer are more likely to be non-smokers and non-drinkers, and less likely than their non-transplant counterparts to survive past one year of diagnosis, according to a new study from Henry Ford Hospital in Detroit.

30 Jan 2012

Pleasurability of scratching for itch relief is related to body location

New research from Gil Yosipovitch, M.D., Ph.D., professor of dermatology at Wake Forest Baptist Medical Center and a world-renowned itch expert, shows that how good scratching an itch feels is related to the itch's location.

30 Jan 2012

CDC publishes an in-depth analysis of Mogellons disease

Experts explain that Morgellons is not an official diagnosis but a syndrome of unexplained symptoms including abnormal sensations that sufferers describe as the feeling of insects crawling on the skin. Symptoms also include fatigue. And, perhaps most peculiarly, one symptom is tiny fibers found embedded in waxy scabs on the skin.

29 Jan 2012